A Study to Evaluate the Lipid Regulating Effects of 1-Methylnicotinamide (1-MNA)

Clinical trial NCT00519714 · COMPLETED

Trial details

NCT number: NCT00519714
Sponsor: Montreal Heart Institute
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hypertriglyceridemia

Start date: 2007-09-01
Primary completion: 2008-10-01
Enrollment: 195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.